Literature DB >> 22348652

Diagnostic utility of dermatoscopy in hydroquinone-induced exogenous ochronosis.

Sunil N Mishra1, Rachita S Dhurat, Deepal J Deshpande, Chitra S Nayak.   

Abstract

BACKGROUND: Hydroquinone is the preferred topical bleaching agent used in the treatment of melasma. The adverse effects of its chronic use are confetti-like depigmentation and exogenous ochronosis. Exogenous ochronosis manifests clinically with gray-brown or blue-black hyperpigmentation, as well as pinpoint hyperchromic caviar-like papules over the malar region. Dermatoscopic findings of ochronosis are unique and point towards a clue for its diagnosis.
METHODS: Three cases of suspected hydroquinone-induced exogenous ochronosis while treating melasma were subjected to dermatoscopy and histopathology studies.
RESULTS: Dermatoscopy in the areas of caviar-like hyperpigmentation revealed accentuation of the normal pseudo-rete of the facial skin with amorphous densely-pigmented structures obliterating some follicular opening and multiple thin, short arciform structures. On histopathological examination, curved ochre-colored structures, 'banana-shaped' fibers, were seen in the dermis of all patients.
CONCLUSION: Exogenous ochronosis is difficult to treat. Dermatologists should be able to differentiate it from melasma and immediately discontinue hydroquinone. Exogenous ochronosis has characteristic features on dermatoscopy which may obviate the need for an invasive procedure of biopsy for its diagnosis.
© 2012 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22348652     DOI: 10.1111/j.1365-4632.2011.05305.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  8 in total

1.  Exogenous ochronosis in a Chinese patient: use of dermoscopy aids early diagnosis and selection of biopsy site.

Authors:  Wen Chun Liu; Hong Liang Tey; Joyce Siong See Lee; Boon Kee Goh
Journal:  Singapore Med J       Date:  2014-01       Impact factor: 1.858

2.  [Progressive facial hyperpigmentation].

Authors:  A Blumeyer; J Röwert-Huber; A Nast; U Reidel
Journal:  Hautarzt       Date:  2016-11       Impact factor: 0.751

3.  A Mixture of Topical Forms of Polydeoxyribonucleotide, Vitamin C, and Niacinamide Attenuated Skin Pigmentation and Increased Skin Elasticity by Modulating Nuclear Factor Erythroid 2-like 2.

Authors:  Hyoung Moon Kim; Kyung-A Byun; Seyeon Oh; Jin Young Yang; Hyun Jun Park; Moon Suk Chung; Kuk Hui Son; Kyunghee Byun
Journal:  Molecules       Date:  2022-02-14       Impact factor: 4.411

4.  Effective reduction of post-inflammatory hyperpigmentation with the tyrosinase inhibitor isobutylamido-thiazolyl-resorcinol (Thiamidol).

Authors:  Dennis Roggenkamp; Ncoza Dlova; Tobias Mann; Jan Batzer; Julia Riedel; Martina Kausch; Ivica Zoric; Ludger Kolbe
Journal:  Int J Cosmet Sci       Date:  2021-05-05       Impact factor: 2.970

5.  Efficacy and tolerability on melasma of a topical cosmetic product acting on melanocytes, fibroblasts and endothelial cells: a randomized comparative trial against 4% hydroquinone.

Authors:  E Bronzina; A Clement; B Marie; K T Fook Chong; P Faure; T Passeron
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-01-12       Impact factor: 6.166

6.  Efficacy and Safety of Topical Therapy With Botanical Products for Melasma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Tianyun Wang; Youmei Wang; Jue Wang; Hongwei Chen; Biao Qu; Zheng Li
Journal:  Front Med (Lausanne)       Date:  2022-01-24

Review 7.  Melasma: an Up-to-Date Comprehensive Review.

Authors:  Oluwatobi A Ogbechie-Godec; Nada Elbuluk
Journal:  Dermatol Ther (Heidelb)       Date:  2017-07-19

8.  Dermoscopic Features of Acquired Brachial Cutaneous Dyschromatosis (ABCD): A New Evolving Investigative Tool.

Authors:  Ramesh Kumar; Shivani Saini
Journal:  Indian J Dermatol       Date:  2021 Sep-Oct       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.